TAKEDA PHARMACEUTICAL CO LTD Chief Transformation Officer Duprey Lauren Rusckowski sold 34,535 shares at $18.54 per share on Sep. 14, leaving her with 191,522 shares. The transaction represented about 15.3% of her prior holding, giving investors a precise view of the sale’s size and remaining ownership.

Key Highlights

  • Duprey Lauren Rusckowski serves as TAKEDA PHARMACEUTICAL CO LTD’s Chief Transformation Officer.
  • The transaction took place on Sep. 14, 2026.
  • The sale was classified under transaction code S.

TAKEDA PHARMACEUTICAL CO LTD (NYSE: TAK) Chief Transformation Officer Duprey Lauren Rusckowski sold 34,535 shares at $18.54 per share. The transaction left Rusckowski with 191,522 shares.

Sale Details and Transaction Classification

The transaction occurred on Sep. 14, 2026, and involved shares of TAKEDA PHARMACEUTICAL CO LTD. Transaction code S identifies the trade as a sale. Rusckowski’s position as Chief Transformation Officer was listed alongside the transaction. The reported sale price was $18.54 for each share transferred.

Remaining Ownership After the Transaction

Rusckowski’s post-transaction holding stood at 191,522 shares. The 34,535-share sale represented about 15.3% of her prior shares holding. The percentage is tied to her ownership before the transaction, while the 191,522 figure reflects the shares remaining afterward.